NOWDiagnostics, Inc. raised $22.5 million in Series B funding led by DigitalDx Ventures with Labcorp Venture Fund and Kompass Kapital Management participating
Amount Raised
$22.5 Million
Round Type
Series B
Investors
Description
NOWDiagnostics, Inc. (NOWDx) has secured $22.5 million in Series B financing. The oversubscribed funding round will be used to drive the commercialization of at-home diagnostic tests, continue developing new diagnostic innovations, expand the pipeline of tests, and support strategic hiring initiatives.
Who else raised in Healthcare and Medical Device around the same time
Companies in the same sectors as NOWDiagnostics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Endovia Health Sciences, Inc. raised $600K (Seed) on August 22, 2024.
- Revolution-ZERO raised $321K (Funding Round) on August 16, 2024.
- Neochord raised $914K (Seed) on August 16, 2024.
- Aevice Health raised $7M (Seed) on August 12, 2024.
- Xtant Medical Holdings raised $5M on August 9, 2024.
- Otolith Labs raised $4.9M (Series A) on July 29, 2024.
Who to call at NOWDiagnostics, Inc., and when
A new round usually means NOWDiagnostics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NOWDiagnostics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NOWDiagnostics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NOWDiagnostics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NOWDiagnostics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNOWDiagnostics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.